Measles and rubella monitoring report, November 2012
The ECDC measles and rubella monitoring report presents regular updates on measles and rubella transmission in Europe based on reporting from EU and EEA/EFTA countries and ECDC epidemic intelligence activities. This enhanced surveillance report supports efforts by EU Member States and international partners to eliminate measles, rubella and congenital rubella syndrome in EU and the WHO region of Europe by 2015.
The number of reported cases in European Union Member States is substantially lower in 2012 compared with the same period in 2011, but the notification rate for the last 12-month period continues to exceed the elimination target of less than one case per million population.
According to the ECDC monthly measles and rubella report, 11 out of 29 reporting countries met the elimination target of less than 1 case per million population during the last 12 months. These are Bulgaria, Denmark, Finland, Greece, Hungary, Iceland, Lithuania, Malta, Netherlands, Portugal, and Slovakia.
There were 5 640 reported cases of measles from January to September 2012 and 8 054 cases during the last 12-month period from October 2011 to September 2012. France, Italy, Romania, Spain and the United Kingdom contributed 93% of the notified measles cases.
There was no increase in cases at the European level during the peak transmission season from February to June this year.
From 1 January to 31 September 2012, 25 759 cases of rubella were reported by 26 EU and EEA countries; 30 116 rubella cases were reported from October 2011 to September 2012. Poland and Romania accounted for 99% of all reported rubella cases during the last 12-month period.
Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report for 2019
18 Nov 2020 - This report is based on data reported to the European Antimicrobial Resistance Surveillance Network (EARS-Net) for the period 2015 to 2019, retrieved from The European Surveillance System (TESSy) and ECDC’s decentralised data storage for antimicrobial resistance and healthcare-associated infections (ARHAI) on 10 September 2020.
Antimicrobial consumption - Annual Epidemiological Report for 2019
18 Nov 2020 - In 2019, the average total (community and hospital sector combined) consumption of antibacterials for systemic use (Anatomical Therapeutic Chemical (ATC) group J01) in the EU/EEA was 19.4 defined daily doses (DDD) per 1 000 inhabitants per day (country range: 9.5–34.1). During the period 2010–2019, a statistically significant decrease was observed for the EU/EEA overall.
Influenza virus characterisation, October 2020
13 Nov 2020 - This is the first report for the 2020–2021 influenza season. As of week 44/2020, only 39 influenza detections across the WHO European Region had been reported to The European Surveillance System (TESSy); 59% type A viruses, with A(H3N2) prevailing over A(H1N1)pdm09, and 41% type B viruses with none having been ascribed to a lineage. This represents a 97% drop in detections compared with the same period in 2019, probably due to the COVID-19 pandemic and measures introduced to combat it.